There are 13 resources available
Welcome and Learning Objectives
Presenter: J. Edeline, FR and A. Lamarca, ES
Session: Welcome and Introduction
Resources:
Slides
Webcast
What is Cholangiocarcinoma (Primary Site, Molecular Biology, Epidemiology)?
Presenter: T. Macarulla, ES
Session: Session 1 – Knowing Cholangiocarcinoma and the Patients
Resources:
Slides
Webcast
Symptom Management When Treating Patients with Cholangiocarcinoma
Presenter: J. Edeline, FR
Session: Session 1 – Knowing Cholangiocarcinoma and the Patients
Resources:
Slides
Webcast
Patient Perspective: What Should the Oncologist Treating Cholangiocarcinoma Take into Account?
Presenter: H. Morement, UK
Session: Session 1 – Knowing Cholangiocarcinoma and the Patients
Resources:
Slides
Webcast
Adjuvant Treatment: Is Capecitabine the Standard of Care?
Presenter: J. Bridgewater, UK
Session: Session 2 – Adjuvant and Neoadjuvant Treatment for Cholangiocarcinoma
Resources:
Slides
Webcast
Neoadjuvant Treatment: Is Perioperative Treatment Coming or Could it Have a Role?
Presenter: L. Rimassa, IT
Session: Session 2 – Adjuvant and Neoadjuvant Treatment for Cholangiocarcinoma
Resources:
Slides
Webcast
Locoregional Therapies: How Can we Improve the Study Design?
Presenter: J. Edeline, FR
Session: Session 3 – Locoregional Therapies for Cholangiocarcinoma
Resources:
Slides
Webcast
Chemotherapy: First Line and Second Line. How is the Field Moving Forward?
Presenter: A. Lamarca, ES
Session: Session 4 – The Management of Advanced Disease: Chemotherapy and Immunotherapy
Resources:
Slides
Webcast
Immunotherapy: Rationale, Current Data and Upcoming Studies
Presenter: A. Vogel, DE
Session: Session 4 – The Management of Advanced Disease: Chemotherapy and Immunotherapy
Resources:
Slides
Webcast
Targeted Therapies FGFR and IDH: Current Data and Compounds in Advanced (Phase II and Beyond) Stage of Development
Presenter: M. Lowery, IE
Session: Session 5 – The Management of Advanced Disease: Targeted Therapies and New Treatment Options
Resources:
Slides
Webcast